Year: 2020

PARSIPPANY, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 Jefferies Virtual London Healthcare Conference at 2:05 PM GMT (9:05 AM ET) on Tuesday, November 17, 2020. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.About Pacira         Pacira BioSciences, Inc. (NASDAQ: PCRX) is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States...

NEW HAVEN, Conn., Nov. 10, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced that management will present a Company overview, as well as host virtual investor meetings, at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020.Presentation Time: 10:00 a.m. ETA live webcast of the presentation can be accessed by visiting ‘News & Events’ in the ‘Investors & News’ section on the Company’s website at www.trevitherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company’s website following the conference.The Company’s corporate presentation is posted to its website in the...

PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced financial results for the third quarter ended September 30, 2020 and provided a business update.“With patient enrollment now underway for our lead program, DSG3-CAART, for patients with mucosal pemphigus vulgaris, we are on track to report acute safety data from the first cohort of patients in the first half of next year. During the quarter, we opened a second site for the trial and also published comprehensive preclinical proof of concept data in The Journal of Clinical Investigation further validating the mechanism of action of DSG3-CAART,” said Steven Nichtberger, M.D.,...

HOUSTON, Nov. 10, 2020 (GLOBE NEWSWIRE) — TC PipeLines, LP (NYSE: TCP) (the Partnership) today reported net income attributable to controlling interests of $65 million and distributable cash flow of $36 million for the three months ended September 30, 2020.“During the third quarter of 2020, our diversified portfolio of essential energy infrastructure continued to perform well and generated solid results,” said Nathan Brown, president of TC PipeLines, GP, Inc. “These results continue to highlight the resiliency of our assets during these unprecedented times. We also continued to advance our suite of organic growth projects with PNGTS’ Portland XPress project being placed into service on November 1 as planned and our other projects progressing on schedule.”“Despite our third quarter net income being sixteen percent higher year-over-year...

LeafLink is live in 26 territories across North AmericaLeafLink analyzes orders between 1,700+ cannabis brands & 5,500+ retailersFastest-Growing categories represent the most popular brands and products on their platformVANCOUVER, British Columbia, Nov. 10, 2020 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that its wholly-owned subsidiary Ganja Gold has been recognized by LeafLink as the fastest growing pre-rolls in the nation.LeafLink, live in 26 territories across North America, created LeafLink List by analyzing the orders between 1,700+ cannabis brands and 5,500+ retailers. The Fastest-Growing categories represent the most popular brands and products on the platform in 2020.“We are...

– Completed Initial Public Offering of Common Stock, Raising Gross Proceeds of ~$181.9M –– Partial Response Confirmed in Glioblastoma Multiforme Patient in Phase 1 Trial of PRT811 –– Durable Complete Response Ongoing in HRD+ High Grade Serous Ovarian Cancer Patient in Phase 1 Trial of PRT543 –WILMINGTON, Del., Nov. 10, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”, “the Company”, “we”) (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced its financial results for the third quarter ended September 30, 2020 and provided an update on recent developments.“Prelude has evolved substantially to become a clinical-stage precision oncology company with multiple small molecule oral agents currently advancing through clinical trials,” said Kris Vaddi, PhD, Chief...

TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO) (the “Company” or “Emerita”) announces that it has submitted the initial drill program for the West Iberian Belt Project (Figure 1) (formerly referred to as the “Paymogo Project”) (the “Project”) to the mining authorities in Andalusia and the program has been accepted. The exploration permit granted to Emerita is officially published on the Andalusia Mining portal on the Junta de Andalusia web site. This is a requirement of the permitting process by the Department of Mines of Huelva province, where the Project is located. The Department of Mines is responsible for consulting with the environmental department of Huelva province to secure the environmental permit and authorize the exploration activities.Figure 1: Location of West Iberian Belt Project. https://www.globenewswire.com/NewsRoom/AttachmentNg/a75d67cf-5aa6-47bd-a6af-467479ab91e3There...

FORT LAUDERDALE, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) — Recovery First Treatment Center, a leading provider of substance use treatment services in Florida, has partnered with Aventura Hospital and Medical Center to offer a rotation in addiction treatment for psychiatry residents. Future psychiatrists receive educational course work and hands-on training alongside the treatment center’s medical and clinical teams to further understand the distinctive care required in treating the disease of addiction.“Aventura Hospital and Medical Center is an esteemed facility in terms of care and instruction, so it is an honor for Recovery First to have a hand in treating its residents,” said Denise O’Connell, CEO of Recovery First Treatment Center. “As we endure both the coronavirus and opioid crises simultaneously, it is becoming increasingly evident...

 Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining10 November 2020Vast Resources plc(‘Vast’ or the ‘Company’)Atlas Special Opportunities LLC Non-Conversion AgreementVast Resources plc, the AIM-listed mining company, announces that the Company has entered into a non-conversion agreement with Atlas Special Opportunities LLC (‘Atlas’) regarding the Tranche 1 Bonds issued to Atlas, announced on 31 January 2020, under the terms of the Atlas Bond Issuance Deed (‘Bond Issuance Deed’).Under the terms of the Bond Issuance Deed, since 29 July 2020 Atlas has and continues to be entitled to exercise conversion rights. Atlas has informed Vast of its intention to exercise certain conversion rights and in the event that Atlas excercises these conversion rights then under the provisions of the Bond Issuance Deed the Company has the right...